Provided by Tiger Trade Technology Pte. Ltd.

Hillhouse Capital Holdings

4,662.96
+3.260.07%
Number of Gainers:48
Number of Losers:15
Number of Flat:2
PE:- -
High:4,702.52
Open:4,659.02
Low:4,657.82
Close:4,659.62
Volume:209.27M
Turnover:13.27B
Market Cap:8.34T
Float Cap:7.87T

Loading ...

Analysts Offer Insights on Technology Companies: Intel (INTC) and Salesforce (CRM)

TIPRANKS
·
Aug 12

Alphabet's New Pixel 11 Smartphones Put Gemini AI at the Center, Setting the Stage for a Clash with Apple's iPhone

Deep News
·
Aug 12

Airbnb’s (ABNB) Growth Story Is Far From Over

TIPRANKS
·
Aug 12

Chengdu Auto Show opens next week with nearly 120 brands, 1,600 vehicles

CnEVPost
·
Aug 12

Prelude Therapeutics Incorporated Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 12

Root and TheZebra.com Partner to Expand Access to Personalized Insurance Options for Consumers and Independent Agents

GlobeNewswire
·
Aug 12

Cogent Biosciences, Inc. : Leerink Partners Cuts Target Price to $60 from $72

THOMSON REUTERS
·
Aug 12

Century Therapeutics Reports Q2 Results, Pipeline Advancements

TIPRANKS
·
Aug 12

Salesforce is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
Aug 12

NIO (NIO) Stock Looks Near Fair Value On Battery Swap Expansion

Simply Wall St.
·
Aug 12

Palantir and These Software Stocks Slide in Seesaw with Chip Giants

Dow Jones
·
Aug 12

Snowflake Inc. : Oppenheimer Raises Target Price to $400 from $295

THOMSON REUTERS
·
Aug 12

Legend Biotech Corp. : Oppenheimer Cuts to Perform from Outperform

THOMSON REUTERS
·
Aug 12

Century Therapeutics Q2 Net Loss Misses Estimates on Lease Termination Loss

Reuters
·
Aug 12

Century Therapeutics Q2 Net Income USD -34.55 Million Vs. IBES Estimate USD -22.4 Million

Reuters
·
Aug 12

Keurig DR Pepper - Appoints Aaron Alt as Director Effective August 14, 2026

THOMSON REUTERS
·
Aug 12

Keurig DR Pepper Announces Appointment of New Director to Its Board

THOMSON REUTERS
·
Aug 12

Century Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates

THOMSON REUTERS
·
Aug 12

Century Therapeutics Q2 Operating Expenses USD 36.527 Million

THOMSON REUTERS
·
Aug 12

Century Therapeutics Q2 Basic EPS USD -0.17

THOMSON REUTERS
·
Aug 12